In addition to the work the AMA is doing on the Recovery Plan, we are also advocating at the federal and state levels on key issues in public health.
- Advocated for manufacturers to submit over-the-counter (OTC) applications for naloxone and that the FDA help make naloxone available OTC; the FDA approved its first naloxone product to be available for OTC status in March. The AMA is continuing advocacy efforts to urge manufacturers to responsibly price naloxone and for insurers to continue to cover the lifesaving medication.
- Encouraging the administration to provide flexibility in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) Food Packages to better reflect cultural and medical needs and personal preferences while promoting growth and health in women and children.
- Advised the U.S. Department of Agriculture to revise its Child Nutrition Programs to limit the fat, added sugar and sodium content in school-based food programs, and accommodate food substitutions based on cultural and medical needs and preferences.
- Pushing lawmakers to adopt common-sense steps to prevent avoidable deaths and injuries caused by firearm violence.
- Partnering with state medical associations to shape state-level initiatives and legislation.
- Continuing to work with a coalition on ensuring the continuation of and increase in the funding for firearm violence prevention research.
The AMA works to generate support for policies critical to the nation’s health care system—and we can’t do it without your help. Learn more about ways to get involved with AMA advocacy.